News

EMVO informs, that prototype and first phase of development for AMS HUB has been completed. AMS HUB solution is currently under system test by provider (started at September 17). Next milestone would be production pilot phase – October 4.

To guarantee the safety and authenticity of medicines to patients, in the first half of 2021, 12 million packages of medicines were verified in the system and reached consumers in Latvia, according to the Latvian Medicines Verification Organization (LZVO) data

The Latvian Medicines Verification System (LZVS) has successfully passed all compatibility tests so that the Latvian national system is prepared for European Medicines Verification System (EU Hub) updates / system release 1.9. LZVS is ready to work without interruption and restriction

In the first quarter of 2021, in the medicines verification system, which guarantees the safety and authenticity of prescription medicines, 5.8 million packages of medicines were verified and have reached consumers.

On 13 January 2021, the European Commission adopted a new Delegated Regulation, amending Delegated Regulation (EU) 2016/161 as regards a derogation from the obligation of wholesalers to decommission the unique identifier of products exported to the United Kingdom.

The Latvian medicines verification system, which was established in Latvia to check the safety of medicines and prevent people from receiving or buying falsified medicines, has been fully operational for almost two years.